@article{c4aa3b2f4cc34ba09f7c199e213cfe0f,
title = "Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study",
keywords = "Age-appropriate medicines, Best Pharmaceuticals for Children Act (BPCA), Beyond use date, Formulation, Infant, Patient-centric, Pediatric Investigation Plan (PIP), Pediatric Research Equity Act (PREA), Solution, Suspension, Toddler, WHO Essential Medicines",
author = "Fadda, \{Hala M.\} and Hannah Weiler and Maria Carvalho and Lee, \{You Zhuan\} and Hadi Dassouki and Rasha AbuBlan and Sonia Iurian and Aasma Hamid and G{\"o}khan {\c S}eremet and Zhiping Li and Catherine Tuleu and Paola Minghetti and Pauletti, \{Giovanni M.\}",
note = "Publisher Copyright: {\textcopyright} 2024 Elsevier B.V.",
year = "2024",
month = nov,
doi = "10.1016/j.ejpb.2024.114483",
language = "English",
volume = "204",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
}